Dainippon Sumitomo to buy out U.S. drugmaker Sepracor
OSAKA, Japan - Photo taken Sept. 3 shows the headquarters of Dainippon Sumitomo Pharma Co. in Osaka. The company said the same day it has agreed to buy out Sepracor Inc., a Massachusetts-based pharmaceutical maker, for around $2.6 billion in an attempt to tap into the U.S. market. (Kyodo)
- Product Code
- ILEA000043543
- Registered date
- 2009/9/03 00:00:00
- Credit
- Kyodo / Kyodo News Images
- Media size
- 1303 × 1865 pixel
- Deployment size
- 800.54(KB)*
*File size when opened in Photoshop, etc.